1. Introduction {#s0005}
===============

Neurosurgical procedures in or close to the motor cortex can be complicated by permanent motor deficits. To prevent damage while aiming to maximize resection, functional mapping is required, especially in tumor surgery, where anatomy can become distorted and functional reorganization can have occurred. In functional mapping, we aim to outline the cortical motor representation ([@bb0080]) i.e., the cortical area that is necessary and sufficient for the generation of movement, rather than only the hotspot of a specific muscle. The current gold-standard to delineate the motor cortex is direct electrical cortical stimulation (DCS). DCS is time-consuming, allows for only limited sampling in case of tailored craniotomies and can\'t be used for preoperative planning or patient counselling. fMRI can help localize functions in the brain, but its use in pre-surgical planning is limited by the altered neuro-vascular coupling -especially near lesions with increased vascularization, and the fact that all regions involved in a task become active and not just the essential brain regions ([@bb0030]; [@bb0035]; [@bb0085]; [@bb0110]; [@bb0125]). A non-invasive, well-tolerated brain stimulation technique able to electrically activate brain regions responsible for generating movement directly- transcranial magnetic stimulation (TMS) - seems the most promising technique for reliable functional pre-operative mapping.

TMS over perirolandic brain regions can lead to motor evoked potentials (MEPs). The resulting MEPs can be measured using electromyography (EMG). The first experiments using TMS for presurgical mapping date back to the nineties ([@bb0050]) but most studies were published after TMS-coils coupled to neuronavigation became commercially available. Even with neuronavigation, only the position of the coil on the scalp is defined and the accuracy of functional mapping depends on our ability to predict from the position of the coil with a diameter spanning over ten centimeters, the exact location and spread of activation in the brain. Previous studies testing TMS mapping prior to tumor surgery reduced the effect of a TMS stimulation to a single point projected onto the cortex, used a point-cloud to represent the TMS samples and derived the motor representation from it based on a fixed threshold. Operationalizing the similarity between TMS data and DCS data, has been done in a number of ways. For TMS this was done using either the location of the stimulus eliciting the largest MEPs (e.g. [@bb0020]; [@bb0095]), the location of the stimulus eliciting MEPs at the lowest stimulation intensity (e.g. [@bb0070]) or by calculating the center of gravity (CoG, i.e. the geometrical midpoint) of the thresholded outline (e.g. [@bb0090]; [@bb0130]). Average distance measures varied between studies from 2.1 mm ([@bb0095]) to 10 mm ([@bb0020]; [@bb0070]) and more, depending on the muscle of interest, and with a large range. More detailed maps of the motor representation can be obtained from this point-cloud by spline interpolation ([@bb0080]). The thresholding is based on measured MEP-amplitudes known to show considerable trial-to-trial variability ([@bb0010]) and to be dependent on the relative orientation of the induced electrical field with respect to the underlying brain anatomy and properties of tissues underneath the TMS coil ([@bb0055]; [@bb0100]). To improve the localization of the motor cortex, modelling of the induced electrical field might be useful, taking into account the coil properties, its orientation and the properties of different tissue classes that make up the inside of the head ([@bb0120]). Several algorithms have been published to calculate the induced electric field, e.g. the SimNibs workflow ([@bb0105]). In this study, we tested several ways of calculating the motor representation, with increasing complexity, and compared the maps with intraoperative DCS data of patients with Rolandic brain tumors. Our aim was to determine what model is best suited to determine the motor representation and to make suggestions to optimize TMS mapping data analysis for clinical practice.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

Patients with tumors close to or extending into the motor cortex were prospectively invited to undergo TMS mapping prior to neurosurgery, between February 2014 and September 2016. Active epilepsy and treatment with anti-epileptic drugs (AEDs) was not a contra-indication for participation since the safety of TMS in this patient group has been documented to be comparable to healthy subjects ([@bb0065]). A tailored craniotomy based on neuronavigation and fMRI data and intraoperative DCS were performed in all cases. The study was approved by the local Ethics Committee of the University Hospitals Leuven. All patients gave written informed consent.

2.2. Ground truth data: direct electrical cortical stimulation (DCS) {#s0020}
--------------------------------------------------------------------

The neurosurgical team was blinded for the pre-operatively acquired TMS data until after the surgery. During the surgical intervention, DCS data were obtained with the purpose of determining a safe corticotomy. The points of DCS were recorded in the neuronavigation system for off-line analysis (BrainLab, Germany). The locations of the points sampled on the navigation scan were extracted with a research tool provided by BrainLab. Since the craniotomy often caused some brain deformation, resulting in small shifts of the cortical surface compared to preoperative images, the DCS points were projected onto the nearest point of the cortical surface in the pre-operative MR imaging (see below) prior to further analysis. To serve as ground truth for comparison with the TMS maps, a binary map of the motor representation was necessary. Hence a DCS stimulation resulting in a motor response at any given intensity was thus considered a positive DCS point and the other points as negative; nearest neighbor interpolation was used in order to obtain the binary map from those DCS points. Since no data could be obtained from non-exposed cortex using DCS, the ground truth map was limited to the exposed cortex ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Ground truth binary map derived from direct electrical cortical stimulation (DCS) data- for upper limb in this example.DCS points are represented as squares on the cortical (or tumor = yellow) surface; blue squares: no motor response evoked (in this example in hand muscles) in this location; red squares: motor response evoked in hand muscles in this location, at any stimulation intensity.A binary map of the exposed cortex was derived from these DCS-points, assigning either a positive or negative value to each node of the cortical surface map, based on the value of the nearest DCS point.Fig. 1

2.3. TMS mapping procedure {#s0025}
--------------------------

TMS data were acquired in the days prior to the surgery. During TMS data acquisition, patients were seated comfortably in a chair with a tracker placed on their head for online, non-invasive registration/reference of the head to an anatomical MRI scan. Stimulation was performed with a Magstim Rapid2 (Magstim, United Kingdom), with standard 70-mm figure-8 coil; neuronavigation data and EMG measurements were recorded using BrainSight (Rogue Research, Canada). EMG was measured using pre-gelled Ag/AgCl electrodes affixed in a belly-tendon montage over the muscles of interest, namely abductor pollicis brevis muscle (APB) for the upper limb and tibialis anterior muscle (TA) for the lower limb. Determination of the stimulation intensity was done in accordance to published guidelines ([@bb0025]; [@bb0045]) and set to 110% of the resting motor threshold of the muscle of interest and was kept constant during the procedure. Since MEPs have been shown to exhibit considerable trial-to-trial variability in amplitude ([@bb0010]) and the MEP amplitudes were used in further calculations, care was taken to obtain enough samples. This was done by sampling over a predetermined grid and taking 10 samples on each grid position. Mapping was continued in each direction until no MEP was seen in at least 5 consecutive measurements over the same grid position. Sampling was first performed over a 1x1cm grid and followed by sampling midway between those grid points. MEPs were measured as peak-to-peak amplitudes, of the maximal peak in the 10--90 ms time frame- trials with (voluntary) muscle activity prior to 10 ms were discarded.

2.4. Creation of the individual 3D head models {#s0030}
----------------------------------------------

The anatomical T1- and T2-weighted images of the patients were used as input to generate a 3D volumetric mesh, consisting of different tissue classes, namely skin and subcutaneous tissue, skull, cerebrospinal fluid, grey matter, white matter, ventricles and brainstem with cerebellum, using surface and volume based meshing, as incorporated in the SimNibs workflow ([@bb0120]) ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Individual 3D head model based on anatomical MRI. 3D volumetric mesh-model of an individual subject; left: cut thought the different tissue classes: skin and subcutaneous tissue (pale red), skull (pale pink), cerebrospinal fluid (light blue), grey matter (light blue), white matter (dark blue); right: 3D surface of cortex (grey) and tumor (yellow).Fig. 2

Tumor tissue was segmented manually and incorporated into the volumetric head model, taking care not to cause overlap with any of the other tissue classes. This was accomplished by manual segmentation in combination with meshing and mesh subtraction using VTK ([ww.vtk.org](http://ww.vtk.org){#ir0005}) and correcting resulting meshes using meshfix ([@bb0005]).

2.5. Creation of the different probability maps {#s0035}
-----------------------------------------------

The workflow to create the different models from the TMS mapping data is illustrated in [Fig. 3](#f0015){ref-type="fig"}. The input data are the same for all models: the anatomical MRI and the coil positions and corresponding MEP amplitudes of all TMS-samples. Models can be divided into point-cloud based models (*method 1&2*), induced electric field based models (*method 4*) or a combination of both (*method 3*). Point-clouds were created by projecting the center of the TMS coil from the scalp to the cortical surface, for each sampled position, either to the nearest point (*method 1*) or along the plane perpendicular to the coil surface (*method 2*). From point-clouds a map was created using interpolation in order to obtain a model of the motor representation ([@bb0080]). The electric field induced in the head by the magnetic field of the TMS coil was calculated for each patient and each coil position, based on SimNibs algorithms. We adapted those in order to retain the actual 3D position and orientation of the coil throughout the process to account for the varying coil-scalp distance as the strength of the induced field falls off with the inverse power of the distance, and to include a tumor. In the calculation of the induced field, each tissue class had different conductive properties. In a simpler model, all tissue conductivities were set as equal, which we will called "isotropic"; in "anisotropic" modelling each tissue class was assigned conductive properties based on literature data. In order not to bias the results, we set the conductive properties of the tumor to the same value as the grey matter. Since tumor is also rich in cell bodies, we assumed the conductivity to be most similar to this tissue class, although accurate data are lacking. In order to combine all field calculations of all samples, either the point of maximal field strength on the cortical surface was taken and the maxima of all samples combined into a point-cloud (*method 3*) or a weighted average of all induced fields was calculated, using the MEP amplitudes as weighting factor (*method 4*).Fig. 3Creation of the different probability maps. The position of the TMS coil in space is represented as a 3D Cartesian axis. Its location is reported relative to the position of the head of the subject. This was done by referencing the head of the subject to the anatomical MRI in a previous step and by using neuronavigation to track the TMS coil and the subjects' head. The anatomical MRI of the subject is converted into a realistic 3D model, to obtain a finite element model of the head, with its different tissue classes. All TMS samples are taken into account to generate the different models, together with their respective MEP amplitudes.For method 3 and 4, the induced electric field was calculated for each coil position. This was done by either setting the conductive value of the different tissue classes to the same value, in the "isotropic" modelling, or by assigning realistic conductive properties to each tissue class, in the "anisotropic" modelling. Only the fields obtained in the cortex (and tumour surface) were used for further calculations. Method 3 used the maximal value of the induced field as point of activation, to obtain a map. In method 4 the whole field over the cortex was used and these were combined for the different samples, by obtaining a weighted average, with the MEP value as weighting factor.Fig. 3

2.6. Outcome parameters {#s0040}
-----------------------

Maps created were visualized as 3D models. Our primary outcome parameter was how well the maps predicted the ground truth data, namely the binary DCS-based maps of the exposed cortex. The similarity of each probability map compared to the DCS-map was calculated for each individual patient, and plotted using receiver operating characteristic (ROC) curves in Matlab (Matworks, USA). ROC curves visualize sensitivity and specificity of the TMS-based map compared to the ground truth map, in a threshold-independent way, since all possible thresholds are analyzed. Paired *t*-tests were used to study differences in the sensitivity and specificity of the different models. Moreover, the maps were thresholded and the overall accuracy of the different models was compared. Accuracy was defined as TP + TN/TP + TN + FP + FN (with TP: true positive, TN: true negative, FP: false positive and FN: false negative). These maps were also used to calculate centers of gravity (CoG) and compared to the location of the ground truth DCS points- CoG is the parameter used in most studies (the first study dating back to 1992 ([@bb0115])). For point-cloud based maps, the threshold was set to 50 μV MEP-amplitude. In method 4, a fixed percentage of the maximal value was used as threshold (as suggested in [@bb0080]) since the map is based on the strength of the induced field and not MEP-amplitudes.

3. Results {#s0045}
==========

3.1. Participants and ground truth data: DCS {#s0050}
--------------------------------------------

A flowchart of the patients screened and included can be found in [Fig. 4](#f0020){ref-type="fig"}. Patients\' characteristics are given in [Table 1](#t0005){ref-type="table"}. Twelve surgeries (one patient was operated twice) were included in our study. During neurosurgery, an average of eight (range: 5--11) locations were sampled with DCS. In eleven surgeries distal upper limb muscles were activated with an average of 2 (range: 1--3) positive responses per patient, and in three surgeries (including two that also mapped the upper limb) the distal lower limb was activated with DCS, with 1 positive response per patient.Fig. 4Flowchart of recruitment and selection.Fig. 4Table 1Patients\' characteristics.Table 1AgeGenderPathologyRelapse/previous resection?Prior seizuresAED typeAED doseDCS positive distal upper limb/totalNumber of TMS pulses for upper limb mapping[a](#tf0005){ref-type="table-fn"}DCS positive distal lower limb/totalNumber of TMS pulses for lower limb mapping[a](#tf0005){ref-type="table-fn"}152MHGG WHO IVNYLEV/VPA2000/1500 mg1/113630/11219FLGG WHO IINN----2/81000/8357MHGG WHO IVYYLEV1000 mg1/52680/5430MLLG WHO IIYYCBZ/LEV/VPA600/1500/1750 mg3/72370/7546MLGG WHO IINN----1/101700/10673MHGG WHO IVYYLEV2000 mg3/71190/7770MHGG WHO IVYYLEV1000 mg1/81950/8849MLGG WHO IINYLEV1000 mg1/82800/8933MLCC, NOSNN----0/81/812010[b](#tf0010){ref-type="table-fn"}56MHGG WHO IVNYLEV2000 mg5/92581/912011[b](#tf0010){ref-type="table-fn"}56MHGG WHO IVYYLEV2000 mg3/81751/81851271Fmetastatic RCCNN----2/71800/7[^2][^3][^4]

3.2. TMS mapping procedure {#s0055}
--------------------------

For upper limb mapping, an average of 213 samples (±76) were recorded in 11 patients and 142 samples (range: 120--185) for lower limb mapping in three patients ([Table 1](#t0005){ref-type="table"}). The anatomical MRI used for mapping and creation of the head models was recorded within a median of 17 days prior to surgery, with one outlier who underwent the fMRI 5 months prior to surgery (slow growing lesion).

3.3. Creation of the different probability maps {#s0060}
-----------------------------------------------

A representative example of one patient is shown in [Fig. 5](#f0025){ref-type="fig"}. Models 1--3 represent the location of motor areas, derived from the measured MEP amplitudes and scaled accordingly. Model 4, however, represents the areas where high induced electric fields are expected to generate MEPs.Fig. 5All models for one patient in the study, both for upper and lower limb panel a: DCS points sampled during surgery; panel b: ground truth map (similar to Figure 1) panel c: method 1: based on nearest-point projection, with interpolation over the surface, color coding refers to measured MEP amplitudes (in µV) panel d: method 2: based on projection along a plane perpendicular to the coil, with interpolation over the surface, color coding refers to measured MEP amplitudes (in µV) panel e: method 3 isotropic: based on the maximum of the induced field of each coil position sampled, color coding refers to measured MEP amplitudes (in µV) panel f: method 3 anisotropic: same as panel e but using tissue-specific conductivity values based on known tissue properties panel g: method 4 isotropic: based on MEP-amplitude informed weighted average of all fields, color coded for where high induced fields are likely to result in high MEP-amplitudes (red) and areas of low probability of motor responses (blue)panel h: method 4 anisotropic: same as panel g but using a tissue-specific conductivity value based on known tissue properties.Fig. 5

3.4. Outcome parameters {#s0065}
-----------------------

The ROC curves of the models can be seen in [Fig. 6](#f0030){ref-type="fig"}. Since all point-based interpolated maps never covered the whole exposed cortex, the ROC curves of those models are truncated; the area-under-the-curve (AUC) parameter in those instances is not so meaningful. The average AUC parameter of model 4 isotropic was 79% (±10%) and for the anisotropic model 75% (+/− 10%). The overall accuracy of model 1 was 86%, of model 2 85%, of model 3 isotropic 85%, of model 3 anisotropic 83%, of model 4 isotropic 64% and model 4 anisotropic 80%. Accuracies are driven primarily by the specificity due to the higher number of negative DCS points compared to positive points. Sensitivity and specificity of the different models, at optimal threshold, as based on the ROC curves, are found in [Table 2](#t0010){ref-type="table"}. The best cut-off for model 4 isotropic was around 50% of the maximal value, as reported previously ([@bb0080]) whereas for the anisotropic model, a cut-off of around 40% of maximal (cut-offs were tested with 10% increments ([@bb0080])), performed better - the maximal value obtained with the anisotropic models was on average also 14% higher compared to the isotropic model. 50% and 40% cut-offs respectively were thus used to threshold the map for CoG calculations. However, accuracies of the models at the fixed threshold were similar to the accuracy data obtained from the ROC curves ([Table 3](#t0015){ref-type="table"}). The Euclidian distance between the CoG of a model and the DCS point is on average 11 mm (SD 1.5 mm) ([Table 4a](#t0020){ref-type="table"}, [Table 4b](#t0025){ref-type="table"}). For the six subjects in whom more than one positive DCS point was recorded, the distance measures decreased for the electric field based models when the DCS point was taken where a response could be evoked with the lowest amount of stimulating current instead of the center of the DCS points ([table 5](#t0025){ref-type="table"}); however this difference was not significant in this low number of subjects.Fig. 6Receiver-operator characteristics (ROC) curves of the experimental maps of the subject who's maps are represented visually in Figure 5. Since the point-based methods do not have values for all points of the cortical (and tumour) surface, those graphs are truncated. Sensitivity and specific values are reported for the optimal cut-off. The area under the curse (AUC) for hand is 0.88 for the isotropic method and 0.83 for the anisotropic method; for the foot this is 0.84 and 0.86 respectively.Fig. 6Table 2Sensitivity and specificity of the different models (in %), for the different patients, compared to the DCS data, as calculated from the ROC curves.Table 2Method 1Method 2Method 3 isotropicMethod 3 anisotropicMethod 4 isotropicMethod 4 anisotropicSensSpecSensSpecSensSpecSensSpecSensSpecSensSpecPatient 1 hand319437912095379387868180Patient 2 hand7756678951946188100479655Patient 3 hand3370686877539085487658Patient 4 hand608647625890546178577570Patient 5 hand289833973996539180816574Patient 6 hand339839952399579079746287Patient 7 hand3287488719781010071726760Patient 8 hand508171875776905377707466Patient 9 foot688782833692797794727479Patient 10 hand569664914498129379849273Patient 10 foot41001693109919983768184Patient 11 hand289073772888159660554557Patient 11 foot978594859786479396849396Patient 12 hand497844824876447696288949Mean (+standard deviation)46,1 (27,9)86,1 (7,3)55,9 (24,7)84,8 (5,1)38,3 (23,9)88,7 (9,4)40,2 (33,5)85,7 (16,2)83,2 (13,0)66,7 (18,4)76,4 (16,0)70,6 (15,5)Table 3accuracy (in %) of the different thresholded maps, for the different patients, compared to the DCS based map ('ground truth').Table 3Accuracy thresholdedModel 1Model 2Model 3 isotropicModel 3 anisotropicModel 4 isotropicModel 4 anisotropicPatient 1 Hand899085909086Patient 2 Hand828784868174Patient 3 Hand958381858468Patient 4 Hand857073888445Patient 5 Hand949489949380Patient 6 Hand505453426276Patient 7 Hand888988884553Patient 8 Hand879088868171Patient 9 Foot878578868263Patient 10 Hand788277788566Patient 10 Foot939393939241Patient 11 Hand778076757861Patient 11 Foot959595989662Patient 12 Hand858585854547TotalAll: mean & stand-dev85 (12)84 (11)82 (11)84 (14)78 (16)64 (14)Hand: mean & stand-dev83 (12)67 (11)65 (10)66 (14)60 (17)53 (14)Foot: mean & stand-dev91 (4)91 (5)88 (10)92 (6)90 (7)55 (12)Table 4aDistances (in mm) of the centre of gravity (CoG), using pre-set thresholds, between each of the models and the positive DCS point (single positive DCS point (in 6/12) when only one positive DCS point was recorded or to the midpoint of all positive DCS points (marked with \*)).Table 4aMethod 1Method 2Method 3 isotropicMethod 3 anisotropicMethod 4 isotropicMethod 4 anisotropic1 Hand17.918.515.017.722.125.42^⁎^ Hand12.912.110.010.618.018.73 Hand21.218.724.224.235.837.84^⁎^ Hand9.28.411.15.412.311.85 Hand16.618.314.316.121.423.06^⁎^ Hand8.310.616.414.618.618.97 Hand13.17.19.219.111.014.38 Hand11.913.713.29.013.012.69 Foot7.79.06.36.59.111.710^⁎^ Hand10.46.910.110.39.912.010 FootNaN17.511.0NaN13.220.911^⁎^ Hand17.011.412.812.019.120.511 Foot5.95.98.26.114.018.012^⁎^ Hand4.94.0NaNNaN11.314.4All mean (standard dev)12.7 (5.0)11.3 (5.1)11.5 (4.5)10.8 (5.8)16.7 (7.0)17.5 (7.1)Hand mean (standard dev)13.0 (4.8)11.8 (5.1)13.6 (4.4)13.9 (5.5)17.5 (7.5)19.0 (7.7)Foot mean (standard dev)4.5 (1.3)8.1 (6.0)6.4 (2.4)4.2 (0.3)9.1 (2.6)12.7 (4.7)Table 4bDistances (in mm) of the centre of gravity (CoG), using pre-set thresholds, between each of the models and the single DCS point where a response was evoked using the lowest current, in patients with more than one DCS positive point recorded (in all for mapping of the hand).Table 4bMethod 1Method 2Method 3 isotropicMethod 3 anisotropicMethod 4 isotropicMethod 4 anisotropic26.56.37.18.99.99.142.96.78.810.613.09.066.88.59.411.512.212.2106.56.56.510.214.69.01124.022.413.712.13.81.9124.61.77.27.27.38.3Mean (Stand dev)8.6 (7.7)8.7 (7.1)8.8 (2.6)10.1 (1.8)10.1 (4.0)8.3 (3.4)Table 5Distances (in mm) for the ground truth maps: between DCS mean- that is the midpoint of all positive DCS points or a single positive DCS point (in 6/12) when only one positive DCS point was recorded DCS single- the single DCS point where the response was evoked at the lowest stimulation intensity (if available) and the CoG of the DCS positive maps created by nearest neighbor interpolation.Table 5DCS single-DCS meanCoG-DCS meanCoG-DCS singlePatient 1 hand--8.6--Patient 2 hand8.65.512.9Patient 3 hand--8.8--Patient 4 hand11.46.010.0Patient 5 hand--9.4--Patient 6 hand12.817.912.6Patient 7 hand--3.7--Patient 8 hand--5.4--Patient 9 foot--6.5--Patient 10 hand13.86.27.7Patient 10 foot--2.7--Patient 11 hand16.911.318.0Patient 11 foot--4.5--Patient 12 hand12.810.25.1Mean12.77.611.1Standard deviation2.73.94.5

4. Discussion {#s0070}
=============

TMS is a useful and accepted method to locate the motor cortex prior to neurosurgical procedures. Its accuracy depends on the ability to predict from the position of the coil (with a coil diameter spanning over ten centimeters) placed on the head, the area of activation in the cortex. TMS does affect a whole area of the brain, rather than a single "activation point" as it has often been presented in previous studies. In this study, we created probability maps of the motor cortex that differed only in the way they were calculated, by adding progressively more information. The electric fields were calculated post-hoc from the scalp location- not during the recording- and thus more detailed and computationally complex methods could be used. The modelling could not only take scalp- brain distance and properties of the magnetic coil into account, but all anatomical details of the individual\'s head and the differential conductive properties of tissue classes. The aim was to determine the best way to analyze the TMS data in order to delineate the cortical motor representation, i.e. the cortical area that is necessary and sufficient for motor function. It was shown that simple projection models are accurate (accuracy ≥85%) and can be used to specifically point to a cortical area of the motor cortex (specificity \>95%). However, the spread of activation is not captured. Clinically, these models can be used to pinpoint to a gyrus containing the motor cortex. Using the induced field to determine the point of maximal impact in the brain of the TMS pulse, did not improve the model compared to simple projections. The modelling did not only take scalp-brain distance and properties of the magnetic coil into account, but also all anatomical details of the subjects\' head. In this modelling, the anisotropic model showed often only a very small area of activation; due the inherent local field increases at grey-white matter borders ([@bb0100]) the maxima of samples obtained over larger areas of the scalp coincided on the same focal point at a bend of a sulcal surface. The reason for this lack of additional benefit is that the effect of TMS is more extensive than one focal point- a fact we wanted to capture in the electric field weighted average models. The interpretation of those maps is that regions with high values are those where high induced electric field strengths are likely to result in high MEP amplitudes. These maps can give an outline of the motor were 50% of the maximal value for the isotropic and 40% for the anisotropic model.

For clinical purposes, we suggest to use different thresholds, which is a unique benefit of these maps: a high threshold highlights the center of the motor area and a lower threshold is able to capture the whole motor representation ([Fig. 7](#f0035){ref-type="fig"}). The best accuracy for this type of probability map was obtained by the anisotropic version of this model, which the model that takes all known information of anatomy and conductivity into account.Fig. 7Illustration of the effect of the chosen threshold on the corresponding map. The upper and lower panels represent the same map, but at a different threshold, to demonstrate that with the same map both the area of the motor representation can be shown (although at the cost of some false-positive zones) and the motor "hotspot". This image also illustrates that the anisotropic map is often more suited to gauge the motor representation.Fig. 7

In order for these models to work, care needs to be taken to counter the inherent considerable trial-to-trial variability in MEP amplitudes, for instance by measuring several MEP amplitudes from a similar location and by using an interpolation over the surface, which should limit problems caused by outliers ([@bb0080]), as was done in our study. It should be noted that previous motor TMS studies in neurosurgical patients used a simple curvilinear representation of the cortical surface whereas we used the real cortical surface. This inherently leads to larger Euclidian differences between two points and distance measures. Our results, therefore, are not completely comparable with previous studies. Moreover, the CoG is dependent on the cut-off used and especially for field-based models; the CoG shifts considerably when changing the threshold and is thus not a robust outcome measure. The average distance in our study was 11 mm, depending on the modelling used. The rather low number of DCS points in our study also affected distance measures, but the resulting ground truth map was clinically relevant. It was left to the discretion of the neurosurgeon (who was blinded for the pre-operatively acquired TMS results) to determine the location and number of DCS points, which in this study were based mainly on sulcal anatomy. Previous studies have used a setup were the TMS-based locations of the motor cortex have been used to guide the DCS sampling ([@bb0015]; [@bb0040]; [@bb0060]; [@bb0070]) or have used a much higher number of DCS points ([@bb0075]), both of which can improve distance measures. The ground truth data in our study also did not have any information on contribution of different parts within one gyrus to the resulting motor output, since this was not the aim of the study. The anisotropic induced field based model predicts that different parts of one gyrus contributing unequally to the resulting motor output. Whether this can also be demonstrated using DCS mapping, will need further study. It should also be noted that the modelling in this study was based on priors derived from healthy volunteers. The model could benefit from more knowledge about the differential conductivity of (different parts of) the tumor, especially if it was combined with automated and reliable tumor segmentation. Moreover, TMS based mapping cannot sample selectively from subcortical structures and thus in order to preserve white matter tracts during surgery, another mapping technique will need to be added (like tractography or intraoperative direct subcortical stimulation).

Depending on the clinical question, a different way to analyze the motor TMS data can be chosen. We argue that calculating a realistic head model and obtaining a weighted average electric field based model, is preferable, since it captures more information compared to point-cloud based models is feasible since it is based on data available preoperatively and a workflow with freely available software. The input data can be acquired with a number of different TMS equipment (including coils from different vendors) and software. It is also more robust since the model takes the coil orientation into account and averages out the inherent MEP-amplitude variability. Since acquisition can be done separately from analysis, pooling of data from different centers becomes a possibility and could be exploited to explore the modelling\'s full potential. The output is an easy to manipulate, threshold-adjustable detailed 3D model of the patients\' brain, which can be loaded in the intraoperative navigation software.
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[^1]: Current address: Department of Neurology, UZ Brussel, Laarbeeklaan 101,

    1090 Jette, Brussels, Belgium.

[^2]: Abbreviations: AED: anti-epileptic drugs; CBZ: carbamazepine; LEV: levetiracetam; VPA: valproate; DCS positive upper/total: number of intra-operative positions sampled with DCS during surgery compared to the total number of samples acquired; DCS positive lower/total: same for lower limb responses; HGG: high grade glioma; LCC, NOS: large cell carcinoma, not otherwise specified: metastasis without known primary tumor; LGG: low grade glioma; RCC: renal cell carcinoma; Y: yes, N: no; WHO: world health organisation classification.

[^3]: data for mapping only reported if used in this study- that is, if intraoperatively the limb was also sampled.

[^4]: data are from the same patient, having two surgeries, 7 months apart.
